Linked Data API

Show Search Form

Search Results

386888
star this property registered interest false more like this
unstar this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government which of the four phase 2 or 3 clinical trials for systemic amyloidosis approved since 2004 are still ongoing; and whether any of the trials have produced sufficient positive outcomes to encourage commercial development. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL997 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL996 more like this
star this property question first answered
less than 2015-07-14T15:34:29.553Zmore like thismore than 2015-07-14T15:34:29.553Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386887
star this property registered interest false more like this
unstar this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government whether there are currently any trials for systemic amyloidosis in humans being conducted by the National Institute of Health Research charities or the commercial sector. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL996 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL995 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.297Zmore like thismore than 2015-07-14T15:34:29.297Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386886
star this property registered interest false more like this
unstar this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Bone Marrow Disorders more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government whether they will place in the Library of the House any publications resulting from the phase 3 clinical trials approved for the potential treatment of systemic amyloidosis or multiple myeloma; and what is the National Institute of Health Research’s assessment of progress in these areas. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL995 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>There are four trials for systemic amyloidosis that are designated as ‘ongoing’ in the United Kingdom. These are being conducted by two commercial sponsors, Millennium Pharmaceuticals Inc and A.T. Development Switzerland Sarl (two studies), and one non-commercial sponsor, European Myeloma Network.</p><p> </p><p> </p><p> </p><p>Clinical trial sponsors are required to publish a summary of their trial results to the EU Clinical Trials Register within one year of their trial completing. At that point, these results will become publically available on the EU Clinical Trials Register</p><p> </p><p> </p><p> </p><p>The Department of Health, which funds the National Institute for Health Research (NIHR), is a member of the National Cancer Research Institute (NCRI). NCRI Clinical Studies Groups (CSGs) bring together clinicians, scientists, statisticians and lay representatives to coordinate development of a strategic portfolio of trials within their field. All CSGs interact with clinical research networks, funders (including NIHR) and researchers to develop studies aimed at improving outcomes for patients. The Haematological Oncology CSG has a Myeloma Subgroup and its 2013-14 annual report that includes an assessment of progress in these areas is attached and available on the NCRI website at:</p><p> </p><p><a href="http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf" target="_blank">http://csg.ncri.org.uk/wp-content/uploads/2014/11/NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf</a>.</p><p> </p><p> </p><p> </p><p>We cannot comment on commercial considerations. When the results are known, the commercial potential of these trial’s products will be a matter for the respective trial sponsors.</p><p> </p>
star this property answering member printed Lord Prior of Brampton more like this
star this property grouped question UIN
HL996 more like this
HL997 more like this
star this property question first answered
less than 2015-07-14T15:34:29.197Zmore like thismore than 2015-07-14T15:34:29.197Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
star this property attachment
1
star this property file name NCRI-Haem-Onc-CSG-Annual-Report-2013-14.pdf more like this
star this property title 2013-14 Annual Report more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386885
star this property registered interest false more like this
unstar this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Myeloma more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government when they expect the National Institute of Health Research Technology Assessment programme to publish initial findings from its assessment of the benefits of antibiotic prophylaxis and its effect on healthcare associated infections in myeloma patients. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL994 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-09more like thismore than 2015-07-09
star this property answer text <p>This trial is led by the University of Birmingham. The project is recruiting ahead of schedule and expects to reach its target of 800 in the near future. The target was to do so by the end of November 2015. Publication of initial findings is expected in 2017.</p><p> </p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-09T13:00:57.7Zmore like thismore than 2015-07-09T13:00:57.7Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
386884
star this property registered interest false more like this
unstar this property date less than 2015-07-01more like thismore than 2015-07-01
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Amyloidosis more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government what progress has been made on setting up a study to image amyloid deposition in systemic amyloidosis using hybrid positron emission tomography-magnetic resonance imaging; where the study is located; how many patients have been recruited; when the study is expected to complete its initial work; and where the results will be published. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL993 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2015-07-14more like thismore than 2015-07-14
star this property answer text <p>This is a single centre study at University College London Hospital. It has now been set up and one patient has been recruited and scanned. The current planned date for end of recruitment is 1 October 2016. It is anticipated that the data will be analysed and submitted for publication in a peer reviewed journal within a year of the end of recruitment.</p><p> </p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2015-07-14T15:36:20.96Zmore like thismore than 2015-07-14T15:36:20.96Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
480069
star this property registered interest false more like this
unstar this property date less than 2016-03-17more like thismore than 2016-03-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Nurses: Training more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government what assessment they have made of the prospective impact on the education and training of Registered Nurses of the UK leaving the EU. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL7172 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-03-23more like thismore than 2016-03-23
star this property answer text <p>No work has been undertaken to determine what impact the United Kingdom leaving the European Union would have on the education and training of registered nurses.</p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-03-23T16:26:46.23Zmore like thismore than 2016-03-23T16:26:46.23Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
480068
star this property registered interest false more like this
unstar this property date less than 2016-03-17more like thismore than 2016-03-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Professions: Apprentices more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government what consideration they have given to involving appropriate regulators in the development of degree-level apprenticeships for nursing and other allied health professionals. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL7171 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-03-23more like thismore than 2016-03-23
star this property answer text <p>Apprenticeship standards focus on the knowledge, skills and behaviours required to enable an apprentice to demonstrate mastery of an occupation and, as such, must meet professional registration requirements in sectors where these exist at the relevant level.</p><p> </p><p>The Nursing and Midwifery Council are involved in the development of the Degree Nurse Apprenticeship Standard and will formally be invited to become a member of the Nursing Trailblazer Group.</p><p><strong> </strong></p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-03-23T15:08:28.82Zmore like thismore than 2016-03-23T15:08:28.82Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
480067
star this property registered interest false more like this
unstar this property date less than 2016-03-17more like thismore than 2016-03-17
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Research more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty’s Government, in the light of the Department of Health mandate to NHS England, which requires it to "ensure that the new commissioning system promotes and supports participation by NHS organisations and NHS patients in research funded by both commercial and non<b><i>-</i></b>commercial organisations", what progress has been made in achieving that objective, and how they record such progress. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL7170 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2016-03-23more like thismore than 2016-03-23
star this property answer text <p>The Department formally holds NHS England to account on its delivery against the research objective in the NHS Mandate, a process which will be rolled forward during 2016/17.</p><p> </p><p>Progress has been made in the areas of participation of National Health Service organisations in research, with 98% of NHS trusts recruited into National Institute for Health Research Clinical Research Network Portfolio studies during the course of 2014/15, and 78% of NHS trusts recruiting to commercial contract studies in the same year. In addition, recruitment of participants into such studies increased in 2014/15 compared to the previous year to 618,453 participants. Recruitment into commercial contract studies is at an all-time high, with 34,885 participants in 2014/15; a 35% increase from 2013/14.</p><p> </p> more like this
star this property answering member printed Lord Prior of Brampton more like this
star this property question first answered
less than 2016-03-23T15:08:11.967Zmore like thismore than 2016-03-23T15:08:11.967Z
star this property answering member
127
star this property label Biography information for Lord Prior of Brampton more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
47864
star this property registered interest false more like this
unstar this property date less than 2014-04-09more like thismore than 2014-04-09
star this property answering body
Cabinet Office more like this
star this property answering dept id 53 more like this
unstar this property answering dept short name Cabinet Office more like this
star this property answering dept sort name Cabinet Office more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty's Government, according to the latest data available, how many young people in England were claiming Jobseeker's Allowance at age (1) 18, (2) 19, (3) 20, (4) 21, (5) 22, (6) 23 and (7) 24; and, for each age group, how many were claiming for (a) less than 3 months, (b) 3–6 months, (c) 6–12 months, and (d) 12 or more months. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL6806 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-04-24more like thismore than 2014-04-24
star this property answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p><p> </p> more like this
star this property answering member printed Lord Wallace of Saltaire more like this
star this property attachment
1
star this property file name HL6806.pdf more like this
star this property title UK Statistics Authority Standard Line more like this
2
star this property file name HL6806 ONS188.pdf more like this
star this property title ONS letter - jobseekers allowance more like this
star this property question first answered
less than 2014-04-24T12:00:00.00Zmore like thismore than 2014-04-24T12:00:00.00Z
star this property answering member
1816
star this property label Biography information for Lord Wallace of Saltaire more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this
46008
star this property registered interest false more like this
unstar this property date less than 2014-03-31more like thismore than 2014-03-31
star this property answering body
Department for Transport more like this
star this property answering dept id 27 more like this
unstar this property answering dept short name Transport more like this
star this property answering dept sort name Transport more like this
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
unstar this property question text To ask Her Majesty's Government whether, following the repeal of European Union Directive 2009/40/EC and the agreement of a new directive at Strasbourg on 11 March with regard to the periodic roadworthiness testing of motor vehicles and their trailers, it will be the United Kingdom Government or the European Union Commission that will decide how the new directive is implemented. more like this
star this property tabling member printed
Lord Willis of Knaresborough remove filter
star this property uin HL6486 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2014-04-08more like thismore than 2014-04-08
star this property answer text <p>The European Union Commission does not have a role in deciding how to implement the new Directive. We are already compliant with the new Directive in most areas and will implement appropriately in the remaining areas in consultation with all parties impacted by changes.</p> more like this
star this property answering member printed Baroness Kramer more like this
star this property question first answered
less than 2014-04-08T12:00:00.00Zmore like thismore than 2014-04-08T12:00:00.00Z
star this property answering member
1557
star this property label Biography information for Baroness Kramer more like this
unstar this property tabling member
4151
unstar this property label Biography information for Lord Willis of Knaresborough more like this